High on Drugs. Erythromycin Only in ointment

Size: px
Start display at page:

Download "High on Drugs. Erythromycin Only in ointment"

Transcription

1 High on Drugs Joseph Shetler, O.D. 112 North Main Gordon, NE shetlerg@gpcom.net Part I : Drugs commonly used in optometric practices Antibiotics Fluorquinolones Highly effective Relatively expensive Central ulcerative keratitis Treat moderate to severe conjunctival and corneal infections Ultimate in antibiotics Treat aggressively Every ½ hour to every 15 mins in severe cases Conjunctival infections q2h-qid One drop per instillation Fluorquinolones Ciloxan: ciprofloxacin 0.3% Alcon Vigamox: moxifloxacin 0.5% Alcon Moxeza: moxifloxacin 0.5% Alcon Ocuflox: ofloxacin 0.3% Allergan Zymar: gatifloxacin 0.3% Allergan Zymaxid: gatifloxin 0.5% Allergan Besivance: besifloxacin 0.6% B & &L Quixin: levofloxacin 0.5% Vistakon Iquix: levoflaxcin 1.5% Vistakon Fluoroquinolones Inhibiting bacterial DNA Gyrase, an enzyme necessary for bacterial replication. Highly bactericidal even in low concentrations New to the line-up Aminoglycosides Less expensive Have generics Inhibit protein synthesis Most effective against gram negative, Pseudomonas, also effective against gram positive. Gram positive are becoming increasingly resistant Toxicity Epithelial breakdown, injection inferiorly Edema of eyelid tissue Not generally serious Availability Gentamicin: Sol and ointment Tobramycin: Tobrex Sol and ointment Neomycin: Not available in stand alone medication Erythromycin Only in ointment 1

2 Gentle Good antibiotic prophylaxis Inhibiting protein synthesis Staphylococcal resistance may develop Illotycin Inexpensive Drug of choice for bacterial blepharitis Breaks down cell walls Minimal toxicity Only in ointment form Polymyxin B Combinations Polymyxin B: potent killer of gram negative Destroys the cell s membrane structural and functional integrity Resistance, toxicity, and allergic rxs rare Allergan Trimethoprim, Interfers with folic acid synthesis In combination with Polymixin B Minimally toxic to eye Effective against Haemophilus Influenzae, and Streptococcus Pneumonia Childhood problems, peditricians #1 Rx Treat a full week, q3h Broad Spectrum (Polysporin) Bacitracin & Polymyxin B Good activity against most common pathogens non-toxin to epithelial tissue Hint Adults do not like ointment for daytime therapy. Bacitracin, Polymyxin B, Neomycin Solution and ointment Kills a broad spectrum 5% react hypersensitivity Erythema, mild edema SPK Resolves within a few days Cold compresses or mild steroids I avoid drug for this reason Azasite Azithromycin Inspire Pharmaceuticals Relatively expensive Long half life Dosage one drop q8 hours- q12 hours Inhibits Protein Synthesis Used significantly for pediatrics Glaucoma Medications Beta Blockers Prostaglandin Analogs Docosanoid Compounds 2

3 Alpha Agonist Carbonic Anhydrase Inhibitors Topical Beta Blockers Major workhorses, 25 year track record Most cost effective therapy Inhibit aqueous formation by blocking beta receptors on nonpigmented ciliary epithelium Concerns and side effects 10% of patients do not respond Bronchospasm, contraindicated in patients with asthma Avoid patients with significant Hrt disease The Timolols Timoptic Timoptic XE Betimol Timoptic First Beta Blocker 1978 XE Gel Based Delivery System Available Generically Betimol Not generically substitutable Available in.25% and 0.5% Good studies have shown QD effective as BID Betoptic S Safest Beta Blocker, more selective Blocks Beta 1 receptors only ( Beta 1 are primarily in cardio tissue, Beta 2 are primarily pulmonary Q12h Patients with hx of cardiac problems should avoid Patients with active COPD, emphysema, asthma should use alternative Prostoglandin Analogs Xalatan: Latanoprost Travatan: Travoprost Lumigan: Bimatoprost Systemically safest Enhancement of uveoslceral outflow Loosens the intercellular spaces within ciliary body Side effects Iris darkening Largely cosmetic Irreversible pigment changes 6-12months 5% develop uveitis 2% macular edema Hypertrichosis Darkening, lengthening, and thickening of eyelashes Avoid Prostaglandins History of uveitis, of CME Aphakia Yag posterior capsulotomy Hx of Herpes Simplex Keratitis Xalatan Pfizer 3

4 Significant medical milestone First prostaglandin for first line therapy Squeeze thin-walled bottle gently to avoid spillage Expensive $50-$60 per bottle Just went Generic Spring of 2011 Two weeks to achieve therapeutic affect Best tolerated of prostaglandins Travatan Z: Travoprost BAK Free, decrease in redness Travatan no longer available Alcon Similar to Xalatan Bottles are half filled to facilitate drop per ability Lumigan: Bimatoprost 30% reduction, similar to Travatan Z and Xalatan QD Dosage Greatest tendency to conjunctival hyperemia Opaque bottle Docosanoid Compounds FDA approved in Aug 2000 In use in Japan in 1994 Exact mechanism unknown, thought to enhance trabecular outflow Alpha Agonist Alphagan-P: Brimonidine (Generic) Alphagan-P Nontoxic preservative compared to BAK in Alphagan Primarily inhibit aqueous production Tid Reduces IOP 20-25% Dry mouth and fatigue Headache Alphagan P 0.1% Generic 0.15% and 0.2% Carbonic Anhydrase Inhibitors Reduce the carbonic anhydrase activity in the ciliary processes. Production of Aqueous humor is fx of bicarbonate Avoid in patients with guttata, endothelial compromise, significant ocular surface disease Trusopt: Dorzolamide Useful in asthmatics bid or tid dosage Bitter taste in throat Generic Azopt: Brinzolamide Alcon Performs similar to Trusopt Less stinging Minimal Shaking is required Cosopt 4

5 First glaucoma combination Dorzoamide and Timolol Maleate 30% reduction Bid Generic Oct 2008 Combigan Newest Combined Glaucoma agent Timolol Brimoonidine (Alphagan P) Expensive combination of relatively inexpensive drugs tid dosing Diamox: Acetazolamide Oral Carbonic Anhydrase Inhibitor Not rxable by ODs in NE Clinically effective Common side effects. Paresthesias, digestive problems Contra in renal or pulmonary problems. Allergy Drugs 40 million units of OTC 4 million rxs Acute Care Drugs Acular LS: ketorolac tromethamine, Allergan LS lower dosage 0.4 as opposed to Acular 0.45 Non-steroidal anti-inflammatory Raises sensory threshold of nerve endings to abate itching Approved for inflammation following Cat Qid x 2 wks Available in unit dosage post operatively Alrex Loteprednol etabonate 0.2% First topical coticosteroid, FDA approved for allergies Rarely causes IOP increase or cats Address all signs and symptoms of allergies Particularly effective in cases with considerable conjunctival inflammation Shake prior to instillation Emadine Emedastine Difumarate 0.05% Topical antihistamine Approved for temporary relief of allergy symptoms qid Safe and effective Patanol Olopatadine hydrochloride: Alcon Topical antihistamine with mast cell stabilizer properties. Patanol, 0.1% bid, Pataday, 0.2% is the only antihistamine, mast cell stabilizer approved for once daily use by FDA Zaditor 5

6 Ketotifen fumarate 0.025% Side by side with Patanol Antihistamine/mast cell stabilizer bid dosing Cl wearers install a few minutes before contacts and a few minutes after removal OTC Optivar Azelastine hydrochloride 0.05% Anti-inflammatory activity reduce influx of inflammatory cell Antihistamine properties Mast cell stabilizer Lastacaft Alcaftadine 0.25% Allergan New 2011 Once daily dosing Affinity for a histamine receptor associated with early phase of allergic conjunctivitis Bepreve New Topical 2010 Bepotastine besilate 1.5% No evidence advantage over other histamine receptor blockers $100 compared to OTC at $15.00 OTC All ketorolac fumurate 0.025% Alaway B&L Claritin Eye Schering-Plough Refresh Allergan Zaditor Novarits Chronic Care Drugs Stabilize mast cell membranes No direct anti-histamine or anti-inflammatory properties, poorly suited for acute allergy. Well suited for multiple-wk therapy Inhibiting the degranulation of mast cells, preventing them from releasing histamine Safe and can be used for weeks or months Alocril Alomast qid dosing Alamast Alocril slight yellow color, bid dosing Must be used regularly during at risk season Can be used to treat GPC Used with disposable SCL Due to long term toxicity avoid with annual replacement contact lenses Oral Antihistamines Allergic conjunctivitis, allergic sinusitis, and allergic rhinitis OTC: Benadryl, Chlor-Trimeton For safety and effectiveness Claritin: OTC 10mg qd Clarinex : 5mg qd 6

7 Zyrtec : 5mg, 10mg qd Allegra: 60mg bid, 180mg qd Corticosteroids Myth: elevated IOP: unlikely to occur before 3-5 wks of use Safe and effective treating ocular inflammation Steroids Maximum Clinical Action Pred Forte Inflamase Forte Vexol Lotemax Durezol Pred Forte Prednisolone Acetate 1% Allergan Highly prescribed, clinically proven Greatest anti-inflammatory efficacy Penetrates cornea and AC Iritis, Chemical, Thermal Burns, Episcleritis Avoid in epithelial breakdown and Herpes Simplex Steroids retard epithelial healing Generic Vexol Rimexolone 1% Alcon Similar to Pred Forte Decreased tendency for increased IOP Unique suspension formula re-suspended by picking up the bottle and shaking it minimally Lotemax Loteprednol Etabonate 0.5% Baush & Lomb Treatment of post operative inflammation Site specific Good intra ocular penetration, get to targeted tissue, undergo inactivation Minimal effect of IOP 0.2% formulation is Alrex Also Lotemax ointment Durezol Primarily beneficial due to dosing Frequency. Every 2hours as effective as Pred Forte q1h Moderate Strength Steroids Fluorometholone based Less effective Decreased propensity to elevate IOPs Useful for treating mild to moderate inflammation FML (Allergan) Fluro-Op (Novartis Chronic inflammation Mild to moderate inflammation 7

8 Less likely to increase IOP Available in 0.1%, 0.25% suspension 0.1% ointment Only steroid ointment not in combination Flarex: Alcon Eflone: Novartis More potent than FML Features greater penetration Still does not raise IOPS significantly Hydrocortisone Not available in pure ophthalmic form 1% OTC Treat Blepharodermatits Labels say for external use and not for ophthalmic use Should be applied only to skin Ophthalmic steroids better choice Combination Drugs Steroid antibiotic combination Ocular inflammation associated with risk of infection Good method of providing steroid and antibiotic in one medication Tobradex Tobramycin combination (generic) Dexamethasone 0.1% Solution and ointment Alcon Moderate to Severe Conditions Tobradex ST Dexamthasone 0.05% Xanthum Gum thickening agent allows Lower concentration to be effective Prednisolone & Sodium Sulfate Mild to moderate effect from prednisolone Minimal antibiotic effect Blephamide: Allergan FML-S: Allergan Pred-G Prednisolone-Gentamicin Suspension and ointment form Allergan Stings on insertion Steroid-Neomycin combo Neomycin Allergies Advantage: Price and generic Prednisolone Acetate and Neomycin and polymyxin B Poly-Pred: Allergan, Maxitrol: Alcon NeoDecadron: Dexamethasone neomycin, Merck Zylet New addition by Bausch and Lomb Loteprednol Etabonate Tobramycin (AB) Excellent antibosis Safety of loteprednol NSAID Inflammatory control without steroidal concerns Useful for postoperative treatment ocular inflammation, seasonal allergies 8

9 Pain Management Treatment of cystoid macular edema Very little risk of elevated IOP Voltaren/Acular LS Qid, clinical equivalents Voltaren dicclofenac 0.1% Novartis Acular LS ketorlac 0.4% Acular 0.5% Acular was uncomfortable and stinging upon instillation Acuvail Preservative free unit dose BID one day prior to cat surgery and continued for two weeks immediately post-op Very expensive Two New NSAIDS Nevanc nepafenac 0.1% Alcon Tid Bromoday: Bromfenac First NSAID daily dosing Nsaids not generally rxed beyond a week Potential for Corneal melting Who you gonna call? Proparacaine, Ak-Taine, Alcaine, Ophthetic Works within a minute Effective minutes Burning on instillation Rose Bengal Stings on insertion Stains necrotic cells Identifies Epithelial Break down Use White Light Herpes Simplex Keratitis Antiviral Viroptic: trifluridine Monarch/ Generic Old drug Indiscriminate Potentially toxic More frequent dosing q2h Refrigerate until opened Thiomersal preserved /Solution New Zirgan/ gel Infected cell specific Minimally toxic Less frequent dosing No refrigeration BAK Preserved 9

10 Expensive Fluorescein Sodium Delineates epithelial absence Requires Cobalt filter Slight stinging on insertion Mydriatics and Cycloplegics Dilate the pupil Paralysis accommodation Most frequently used topical medication in practice Effect of medication depends on age, race, eye color Adrenergic Agents Pupil dilation Increase in outflow of aqueous humor Vasoconstriction Relaxation of ciliary muscle Stimulates the iris dilator muscle Adrenergic Agents Avoid Hypersensitivity Narrow angle glaucoma Phenylephrine 10%, Avoid diabetics, hypertensive, aneurysms, cardiac disease, infants and small children, Patients on HTN meds or antidepressant. Avoid 10% Stinging on instillation, photophobia Phenylephrine Hydrochoride Trade names AK-Dilate, Neo-Synephrine Mydfrin, Available generically Soln 2.5%, 10% Onset minutes Duration 3-5 hours Cycloplegic Mydriatics Anticholinergic Block responses of the sphincter muscle of the iris Blocks muscle in ciliary body to cholinergic stimulation Producing pupil dilation and paralysis of accommodation. AntiCholinergic agents Atropine Homatropine Scopolamine Cyclopentolate Tropicamide 10

11 Indications: cycloplegic refraction, dilation in inflammatory conditions Contraindications: glaucoma, narrow AC Hypersensitivity Use with caution: pregnancy, Do not use atropine or homatropine under 3 months Adverse Reactions Increased IOP stinging, hyperemia, photophobia Systemic: Flushing and dryness, rapid irregular pulse, mental aberration, respiratory depression, psychotic reactions Atropine Sulfate Atropisol, Atropine-care, Isopto Atropine, available generically Available in ointment Onset minutes Duration 7-14 days Potent Cyclopentolate Cyclogyl 0.5% Cyclopentolate, AK-Pentolate, Cyclogel, Pentolar 1% Cyclogel 2% Onset minutes Duration 6-24 hours Homatropine Moderately long-acting mydriatic and cyclopelgic for refraction and uveal tract inflammation Homatropine HBr, Isopto Homatropine, 2% Homatropine HBr, Isopto Homatropine, 5% Onset minutes, Duration 3 days Tropicamide Mydriacyl, AK-Tropicacyl: Generic, 0.5 1% Onset minutes Duration 4-6 hours Paremyd Combination 0.25% Tropicamide & 1% Paredrine, Hydroxyamphetamine HBr Hydroxyamphetamine enhances dilation of Tropicamide because dilator muscle is also stimulated, only ¼ to ½ Tropicamide % Onset minutes Duration 3-4 hours Availability is always a concern Fluorescein Sodium & Benoxinate Hydrochloride Contains epithelial dye Anesthetic Routinely for Tonometry Epithelial Evaluation Dry Eye Products Lissamine Green Evaluating dry eye Does Not Sting Stain pattern evaluated for mucin defiency Overview Unit dose vs multidose 11

12 Preservatives vs preservative free Viscosity Gel formulas preservative free and give longer relieve Low viscosity Corneal abrasions UV keratitis Herpes Simplex Herpes Zoster GPC Adenoviral Low viscosity PF or nontoxically preserved GenTeal Mild: multidose GenTeal Hypotears PF: Unit dose Moisture Eyes: Unit dose Refresh Plus: Unit dose Refresh Tears: Multi dose Tears Natural II: Unit dose and multi dose Tears Natural Forte: Multi dose Thera Tears: Unit dose and multi dose Unit Dose Optimal Refresh Plus Moisture Eyes Thera tears Non Toxically Preserved Multi dose GenTeal: Works as SCL and RGP wetting drop Refresh Tears: NA Chlorite which rapidly degrade to CL ions and H20 upon instillation Thera Tears Restore conjunctival goblet cell formation Improve electrolyte balance Micronutrients help restore corneal fx and integrity Unit dosing or 15ml bottle Tears Natural Forte Enhanced Tears Natural II by adding 0.2% glycerin Enhances lubrication Reduces corneal edema Premier Artificial Tears GenTeal Refresh Tears Thera Tears Tears Naturale Forte Soothe Soothe XP Soothe XP stable in dry eye treatment Restoryl (Active ingredient in Soothe XP doubled lipid layer thickness Supports mucin layer Supports Aqueous layer 12

13 Moderate Viscosity Artificial Tears Benefits patients with moderate to advanced tear film instability and epithelial compromise Bion Tears Preservative free Unit dose Bicarbonate Must be kept in foil which can be challenging for arthritic patients OcuCoat PF Preservative Free Bausch and Lomb Sustained Lubrication High Viscosity Artificial Tears Persistent keratitis of unknown etiology Keratitis secondary to a significant dry eye problem Can replace bedtime ointment in patients who need nocturnal lubrication Transient blurring AquaSite Refresh Celluvisc Unit dosage Refresh Liquigel Multi dose Murocel Gel Formulations Initial blur of 1 minute 2-5 hours of symptomatic relief Tube delivery system Highly viscous when coming out of tube May replace high viscosity and ointment Not for use with cls GenTeal Gel Tears Again Lubricating Ointments Uncommonly used Severe enough to warrant nighttime therapy Incomplete closure Severe epithelial compromise Systane New artificial tear Formulation interacts with compromised glycocalyx-mucin-microvillic (foundation of pre corneal tear Demulcent bioadhesive bandage Ph 7.0 interacts with surface 7.4 Gel like coating Prolonged lubrication 15 ml bottle. Refresh Endura Refresh Line of Products Endura is the vehicle of Restatsis Formulation is purported to contribute to all three tear film layers Prolonged lubrication 13

14 Preservative free unit dose Restasis Restasis Cyclosporin, Allergan Action Inflammation of the lacrimal gland and ocular surface tissue is targeted Available in 0.05% unit doses BID Inhibits activated T-Cells Not clinically significant for 3-4 month Full therapeutic affect for 6 months. Expensive: Available in 32 unit dosage for about $100, over $1000 per year May get two day therapy out of unit to cut costs Only 15% of candidates get therapeutic effect 17% of patients experience ocular burning Prescriptive, not OTC Oral Therapy for Dry Eye Nutritional Supplements Omega 3 fatty acid supplementation can be beneficial if meibomian gland dysfx Found naturally in fish oils and flaxseed Render an anti-inflammatory affect Thera Tears Nutrition gel capsule Hydrate Essential Liquid form NaCl for corneal edema Muro 128 solution 2% 5% Reduces corneal edema Ointment of nighttime therapy Vitamin and Mineral supplements Snake oil or beneficial Paul Harvey Says I use Eye Brite What is a Doctor and ParaOptometric to do? Age Related Eye Disease Study 3640 Patients Followed Mean 6.3 years Product used Bausch and Lomb Preser Vision Category 1 No AMD Less than 5 small drusen 20/32 or better vision Category 2 Early AMD mild or borderline Multiple small drusen Pigment abnormalities Category 3 Intermediate AMD 14

15 Absence of advanced AMD One eye better the 20/32 Category 4 Advanced AMD Visual Acuity 20/32 or better, no geographic atropy Fellow eye vision less than 20/32 AMD Advanced, abnormalities to account for reduced vision Results Group taking Preservision had a 25% reduction in rate of AMD progression. Only patients in Category 3 and 4 showed a statistical difference Patients were followed for 6.3 years What to do? Practice evidence based medicine on Category 3 and 4 Practice speculative, rational principles for other categories Recommended two tabs in AM, two more at night Principles to keep in mind Beta-carotene may enhance lung cancer rate in Smokers Vitamin A and Lutein compete for absorption sites, avoid high concurrent doses Vit A D E and K fat soluble and have potential to accumulate to toxic levels Supplementation had no effect on rate of cataract development Role of Lutein Leutin Not commercially prepared at time of study For years at risk patients advised to eat dark, leafy greens Competes with Beta Carotene OcuVite Lutein is recommended as a general health eye vitamin Preser Vision can be regarded as a disease specific vitamin supplement Some practioners are recommending rotation of the two supplements AREDS 2 Results anticipated in 2013 Macular nutrition counseling is part of PQRI System Medications You can t possibly know them all, ie don t feel bad you MD doesn t either Don t be afraid to ask what a medication is for Don t be afraid to ask how to spell a medication. Don t be afraid to check with the pharmacist Don t be afraid to ask for a medication list Try to learn one new drug a week Resources to consider PDR Hard copy Pocket PDR, recommended Clinical Pearls Review of Optometry Your Pharmacist 15

16 Chloroquine Derivatives Plaquenil Arthritis treatment 400mg per day standard dose Yearly exams in healthy patients, previously every 6 months Tamoxifen Another Cholorquine derivative To prevent recurrence of breast cancer and preventative in high risk Causes drusen like deposits in 6%, also cause keratopathy and optic neuritis VA loss is reversible if d/c before less than 20/70, retinal changes permanent MONITOR CAREFULLY Antihistamines Allergic disease, Seasonal allergies OTC various brands Zyrtec, *Allegra, Claritin, Clarinex Dryness of mucosal membranes Dilation of pupils and loss of accommodation in borderline presbyopes, Cardiovascular Drugs Diuretics Can cause transient blur due to fluid loss Diuril, *Lasix, Demadex Potassium Sparing diuretics, Diazide, Aldactone Cardiac Glycosides Digitalis, Digoxin (*Lanoxin) Used for congestive hrt failure, atrial flutter Easy to overdose First signs; Visual disturbance, hallucinations and color vision disturbance Antianginals, nitrates Combined with Viagra, heart stoppage Short Acting, Under tongue, Nitrostat Long Acting Imdur, Isordil Patches Nitrodisk, Nitro-Dur Can cause visual disturbance due to vasodilation effects Antiarrhythmics Calcium channel blockers Indications: arrhythmia, angina, hypertension, migraines Cardizem, Norvasc, Procardia, Verapamil Mechanism, vasodilation of coronary and peripheral vasculature Makes antiplatelet side effect of ASA worse Sever hypotension Beta adrenergic blockers Mechanism, blocks Beta 1 receptors in the heart and slows it Blocks Beta 2 receptors in lungs and eyes, constricts bronchioles and reduces aqueous production Dilates blood vessels Indications, angina, anxiety, HTN, migraine, arrhythmia Examples, * Atenolol, Betaxolol, Inderal, *Lopressor 16

17 Side effects, bradycardia, asthma exacerbation, fatigue depression, IOP reduction ACE (Angiotensin converting enzyme) inhibitors Mechanism, intercepts body s natural vasoconstriction mechanism to reduce blood pressure Indications, HTN, CHF Rarely blurred vision Examples, Lotensin, Capten, Vasotec, Altase, Prinivil Blood Thinners Indications, improve circulation, decrease clotting Examples, aspirin, Warfarin(Coumadin) Side effects, hemorrhage including ocular Cholesterol Lowering Agents Mechanism, inhibit cholesterol synthesis in the liver Indications, hyperlipidemia Examples, Mevacor, Zocar, Lipitor Side effects, rarely conjunctivitis, tearing and blurred vision Oral Hypoglycemics First Generation Stimulates insulin release from the pancreas Examples Diabinese, Tolinase, Orinase Second Generation Stimulates insulin release from the pancreas Examples, Glipizide (Glucotrol) Glyburide (Diabeta, Micronase, Glynase) Insulin sensitizers Examples, Glucophage, Avandia, Rezulin, Side effects, hypoglycemia, refractive changes Injectible Insulin Humulin N Dosage very individualized Stomach Proton-pump inhibitors, suppress gastric acid *Prevacid, Nexium, (the purple pill) Inhibits daytime and nocturnal gastric acid secretions as well as gastric acid stimulated by food, *Zantac Common drugs *Advair, maintenance treatment of asthma *Fosamax, for osteoporosis, acts as inhibitor of bone reabsorption to increase bone density *Premarin, Hormone replacement *Zoloft, Prozac, Paxil, Depression Oral Antibiotics Drug name-brand name Dicloxacillin- Dynapen Cephalexin- Keflex Amoxicillin- Augumentin Cefadroxil- Duricef Ciproflaxin- Cipro Azithromycin- Zithromax Doxycyline- Monodox Levoflaxcin- Levaquin Ofloxacin- Floxin Common AB useage 17

18 Keflex, antibiotic workhorse Works well against bacteria in and around ocular surface Augmentin, expensive Zithromax, chylamidal conjunctivitis single dosage of four 250 mg tablets Antivirals Valuable in managing Herpes Zoster Valuable in treating Herpes Simplex Safe for children with proper dosing Available in liquid form Analgesics OTC Non-Narcotic Narcotic OTC Acteminophen, Tylenol, analgesic, and anti-pyretic, the clear leader ASA, reduces pain, fever, inflammation, but risk of GI bleeding Ibuprofen, Motrin, Advil COX-2 inhibiting drugs Normal prostaglandins, maintenance of gastric mucosa, renal fx, coagulation Inducible prostaglandins response to inflammation. COX-2 inhibitors spare the maintenance mechanism and prevent inflammatory response Oral Nacotics Codeine, Tylenol #3 Mild to moderate pain Hydrocodone, Vicodin Moderate Oxycodone, Percodan Severe 18

CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE

CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE F- 15 CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE Assembled by: Tim Maillet, OD, BSc NSAO Practice Innovations Committee Chairperson September 2009 F- 16 Ocular Allergies

More information

Drugs That May Be Used by Certain Optometrists

Drugs That May Be Used by Certain Optometrists Drugs That May Be Used by Certain Optometrists Approved drugs. (a) Administration and prescription of pharmaceutical agents. Optometrists who are certified to prescribe and administer pharmaceutical agents

More information

Ocular Medication and Compliance

Ocular Medication and Compliance Ocular Medication and Compliance Consultant for Alcon Disclosures CECELIA KOETTING, OD FAAO VIRGINIA EYE CONSULTANTS VOA CONFERENCE NORFOLK 2018 Virginia Optometry License Generic vs Brand Name Every state

More information

OPHTHALMIC MEDICATIONS

OPHTHALMIC MEDICATIONS OPHTHALMIC MEDICATIONS Ally Cuddy, PharmD PGY1 Pharmacy Resident September 7, 2017 AMERICAN ACADEMY OF OPHTHALMOLOGY American Academy of Ophthalmology. 2015. CASE #1 TR is a 76 YOM with no significant

More information

Managing the Patient with POAG

Managing the Patient with POAG Managing the Patient with POAG Vision Institute Annual Fall Conference Mitchell W. Dul, OD, MS, FAAO mdul@sunyopt.edu Richard J. Madonna, MA, OD, FAAO rmadonna@sunyopt.edu Ocular Hypertension (OHT) Most

More information

THE PEDIATRIC RED EYE (Handout)

THE PEDIATRIC RED EYE (Handout) THE PEDIATRIC RED EYE (Handout) Ida Chung, OD, MSHE, FCOVD, FAAO Western University College of Optometry Associate Professor/Assistant Dean of Learning 309 E. Second Street, Pomona, CA 91766 Office: 909-938-4140

More information

Ophthalmic Antihistamine Step Therapy Program Summary

Ophthalmic Antihistamine Step Therapy Program Summary Ophthalmic Antihistamine Step Therapy Program Summary FDA APPROVED INDICATIONS AND DOSAGE 1-8 Drug FDA Indication(s) Administration and Dosing Bepreve Treatment of itching associated Instill one drop into

More information

Financial Disclosure. Prostaglandin Analogs (PGs) The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy

Financial Disclosure. Prostaglandin Analogs (PGs) The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy Danica J. Marrelli, OD, FAAO University of Houston College of Optometry Financial Disclosure I have received I have received speaking

More information

Ophthalmic Medication Review and Update. Scott Ensor, OD, MS Associate Professor Southern College of Optometry

Ophthalmic Medication Review and Update. Scott Ensor, OD, MS Associate Professor Southern College of Optometry Ophthalmic Medication Review and Update Scott Ensor, OD, MS Associate Professor Southern College of Optometry Financial Disclosures None! About Me Native Memphian 2001 SCO Graduate Primary Care Residency

More information

Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.

Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation

More information

4/24/2018. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.

4/24/2018. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation Increase

More information

Completed Clinical Research Trials Monte Dirks, M.D.

Completed Clinical Research Trials Monte Dirks, M.D. Completed Clinical Research Trials Monte Dirks, M.D. Monte Dirks, M.D. - Primary Investigator Norfloxacin -Merck (1986) Safety and efficacy of norfloxacin vs. tobramycin in the treatment of external ocular

More information

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery.

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery. Page 1 of 5 SCHEDULING STATUS Schedule 3 PROPRIETARY NAME (AND DOSAGE FORM) ACULAR 0,5 % COMPOSITION ACULAR 0,5 % contains: Preservatives: Benzalkonium chloride 0,01 % m/v Disodium edetate 0,1 % m/v PHARMACOLOGICAL

More information

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults Treatments for Open-Angle Glaucoma A Review of the Research for Adults Is This Information Right for Me? Yes, this information is for you if: Your eye doctor has said that you have open-angle glaucoma,

More information

1/12/2017. Allergan Pharmaceuticals Speaker s Bureau Bio-Tissue BioDLogics, LLC Katena/IOP Seed Biotech Johnson and Johnson Vision Care, Inc.

1/12/2017. Allergan Pharmaceuticals Speaker s Bureau Bio-Tissue BioDLogics, LLC Katena/IOP Seed Biotech Johnson and Johnson Vision Care, Inc. Jeffrey R. Varanelli, OD, FAAO, Dipl ABO, ABCMO Nicholas Colatrella, OD, FAAO, Dipl AAO, ABO, ABCMO Allergan Pharmaceuticals Speaker s Bureau Bio-Tissue BioDLogics, LLC Katena/IOP Seed Biotech Johnson

More information

Current Protocols Topical and Oral Medications for Ocular Disease

Current Protocols Topical and Oral Medications for Ocular Disease Current Protocols Topical and Oral Medications for Ocular Disease Jill Autry, RPh, OD Eye Center of Texas Ophthalmology Houston, TX DISCLOSURES Jill Autry, OD, RPh Tropical CE Continuing Education Company

More information

PATIENT CASE HISTORY. General Health Medications Allergies

PATIENT CASE HISTORY. General Health Medications Allergies OCULAR PHARMACOLOGY What I Need to Know Before I Medicate A Patient Lynn Lawrence, CPOT, ABOC, COA ROLE of the ASSISTANT AND TECHNICIAN Accurate documentation/recording Patient Education can assist in

More information

! Somatic! Visceral! Neuropathic! Psychogenic. ! Analgesic! Relief without sedation! Works on peripheral pain receptors

! Somatic! Visceral! Neuropathic! Psychogenic. ! Analgesic! Relief without sedation! Works on peripheral pain receptors PAIN, PAIN, GO AWAY. TYPES OF PAIN! Somatic! Visceral! Neuropathic! Psychogenic Jill Autry, OD, RPh Eye Center of Texas, Houston drjillautry@tropicalce.com ANALGESIA! Mild! Aspirin! Paracetamol! Moderate!

More information

12/3/2011. Disclosure. Allergic Eye Disease: Diagnostic Pearls and Treatment Options. Symptoms. Allergy Eye Disease

12/3/2011. Disclosure. Allergic Eye Disease: Diagnostic Pearls and Treatment Options. Symptoms. Allergy Eye Disease Disclosure Allergic Eye Disease: Diagnostic Pearls and Treatment Options I have no financial relationships to disclose. Ophthalmology Update 2011 Matilda Chan MD, PhD Department of Ophthalmology, UCSF

More information

OCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level.

OCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level. OCULAR PHARMACOLOGY GLAUCOMA increased intraocular pressure normally 12 20 mm Hg. when to Tx no fixed level. literature sets ~21 mm Hg as upper limit of normal. some safe at 30 mm Hg some may have damage

More information

Vision Health: Conditions, Disorders & Treatments GLAUCOMA

Vision Health: Conditions, Disorders & Treatments GLAUCOMA Vision Health: Conditions, Disorders & Treatments GLAUCOMA Glaucoma is a disease of the optic nerve, which transmits the images you see from the eye to the brain. The optic nerve is made up of many nerve

More information

Postoperative follow up and treatment after refractive surgery

Postoperative follow up and treatment after refractive surgery Postoperative follow up and treatment after refractive surgery George Kontadakis, MD, MSc, PhD Institute of Vision and Optics and Department of Ophthalmology University of Crete Target of postoperative

More information

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products 1 11.Eye 11.1 - Administration of drugs to the eye Eye-drop dispenser devices (Compleye, Opticare, Opticare Arthro 5, Opticare Arthro 10) are available to aid the instillation of eye drops from plastic

More information

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery. Page 1 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME (and dosage form) ACULAR 0,4% COMPOSITION ACULAR 0,4% ophthalmic solution contains: Ketorolac tromethamine: 4 mg/ml Preservative: Benzalkonium chloride

More information

Challenging Anterior Segment Cases. Benjamin P. Casella, OD, FAAO

Challenging Anterior Segment Cases. Benjamin P. Casella, OD, FAAO Challenging Anterior Segment Cases Benjamin P. Casella, OD, FAAO Bpc81@aol.com Disclosures Have lectured or been a consultant for: Allergan Carl Zeiss Hydrogel Vision 31yoWM My eye is irritated, and I

More information

Elements for a Public Summary. Overview of disease epidemiology

Elements for a Public Summary. Overview of disease epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Epidemiology of the disease Incidence and prevalence Increased pressure in the eye occurs in more than 100 million people, and

More information

10/4/2013. Bruce K.Williams, MSN, RN,ACNP-BC Sisters of Charity Providence Hospitals. What is the worst thing that can go wrong with an eye?

10/4/2013. Bruce K.Williams, MSN, RN,ACNP-BC Sisters of Charity Providence Hospitals. What is the worst thing that can go wrong with an eye? Red Eyes, Red Alert! Bruce K.Williams, MSN, RN,ACNP-BC Sisters of Charity Providence Hospitals Red Eyes, Red Alert! Red Eyes, Red Alert! What is the worst thing that can go wrong with an eye? 1 Red Eyes,

More information

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products 1 11.Eye 11.1 - Administration of drugs to the eye Eye-drop dispenser devices (Compleye, Opticare, Opticare Arthro 5, Opticare Arthro 10) are available to aid the instillation of eye drops from plastic

More information

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy BETAGAN Allergan Levobunolol HCl Glaucoma Therapy Action And Clinical Pharmacology: Levobunolol is a noncardioselective beta- adrenoceptor antagonist, equipotent at both beta1 and beta2 receptors. Levobunolol

More information

BrightFocus Foundation is the new name for American Health Assistance Foundation.

BrightFocus Foundation is the new name for American Health Assistance Foundation. In this section, you will find the following: Glaucoma Medications Laser Therapies Conventional Surgical Procedures In the second section, you will find information on how to search for potential treatments

More information

Comments. Oral Antihistamines. Chronic Drug Treatments. Oral Allergy Medications

Comments. Oral Antihistamines. Chronic Drug Treatments. Oral Allergy Medications Comments: Even though OTC vasoconstrictors and antihistamines are popular, a recent article suggests that these drugs can cause rebound dilation of conjunctival vessels Chronic Drug Treatments Mast Cell

More information

VI.2.2 Summary of treatment benefits

VI.2.2 Summary of treatment benefits EU-Risk Management Plan for Bimatoprost V01 aetiology), both OAG and ACG can be secondary conditions. Secondary glaucoma refers to any case in which another disorder (e.g. injury, inflammation, vascular

More information

Ophthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management Branch

Ophthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management Branch May 2017 Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers Executive Summary Page 1 of 5 Ophthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management

More information

OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST. David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye.

OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST. David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye. OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye.com A FEW OF THE AREAS WE WILL DISCUSS Red Eye Glaucoma Neuro ophthalmic tid

More information

East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults

East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults Introduction Glaucoma is a group of eye diseases causing optic nerve damage. In most cases

More information

Update on Rhopressa TM QD (netarsudil ophthalmic solution) 0.02% and Roclatan TM (netarsudil/latanoprost ophthalmic solution) 0.02%/0.

Update on Rhopressa TM QD (netarsudil ophthalmic solution) 0.02% and Roclatan TM (netarsudil/latanoprost ophthalmic solution) 0.02%/0. Update on Rhopressa TM QD (netarsudil ophthalmic solution) 0.02% and Roclatan TM (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% 1 Important Information Any discussion of the potential use or

More information

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,4 Agent Indication Dosage and Administration Restasis (cyclosporine ophthalmic emulsion)

More information

Essential Topical Formulary. Carlo J. Pelino, OD, FAAO Joseph J. Pizzimenti, OD, FAAO.

Essential Topical Formulary. Carlo J. Pelino, OD, FAAO Joseph J. Pizzimenti, OD, FAAO. Essential Topical Formulary Carlo J. Pelino, OD, FAAO Joseph J. Pizzimenti, OD, FAAO pizzisfl@gmail.com Course Description The ability to use pharmaceutical agents has enabled optometrists to become true

More information

Summary of the risk management plan (RMP) for Izba (travoprost)

Summary of the risk management plan (RMP) for Izba (travoprost) EMA/14138/2014 Summary of the risk management plan (RMP) for Izba (travoprost) This is a summary of the risk management plan (RMP) for Izba, which details the measures to be taken in order to ensure that

More information

Case History. Slit lamp exam: Clinical Pearls in the Management of Iritis. 2- injection: Irregular SPK and staining AC: grade 3 cell & flare

Case History. Slit lamp exam: Clinical Pearls in the Management of Iritis. 2- injection: Irregular SPK and staining AC: grade 3 cell & flare Clinical Pearls in the Management of Iritis Paul Karpecki, OD, FAAO Corneal Services and Ocular Disease Research Koffler Vision Group-Lexington, KY 68 y.o. Caucasian female Complains of photophobia and

More information

Innovation In Ophthalmology

Innovation In Ophthalmology Innovation In Ophthalmology INVELTYS TM Approval August 2018 Disclaimers and Notices This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform

More information

Elements for a public summary. Overview of disease epidemiology

Elements for a public summary. Overview of disease epidemiology VI.2 VI.2.1 Elements for a public summary Overview of disease epidemiology Glaucoma is an eye disease that can result in damage to the optic nerve and loss of vision (blindness). It is the major cause

More information

Core Safety Profile. Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% Date of FAR:

Core Safety Profile. Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% Date of FAR: Core Safety Profile Active substance: Carteolol Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% P - RMS: SK/H/PSUR/0002/002 Date of FAR: 16.03.2012 4.1 THERAPEUTIC INDICATIONS Ocular hypertension

More information

South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension Treatment Pathway

South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension Treatment Pathway Proceed to 2 nd line treatment if further reduction in IOP required and there is good response to PGAs or (& no South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension

More information

NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: TABLE OF CONTENTS

NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: TABLE OF CONTENTS NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: 2012-2013 TABLE OF CONTENTS CONDITION PAGE(S) Complete Eye and Vision Examination 2 Vision Screening Procedure

More information

PRESCRIBING INFORMATION MYDFRIN * Phenylephrine Hydrochloride Ophthalmic Solution. Vasoconstrictor and Mydriatic for Use in Ophthalmology

PRESCRIBING INFORMATION MYDFRIN * Phenylephrine Hydrochloride Ophthalmic Solution. Vasoconstrictor and Mydriatic for Use in Ophthalmology PRESCRIBING INFORMATION MYDFRIN * Phenylephrine Hydrochloride Ophthalmic Solution Vasoconstrictor and Mydriatic for Use in Ophthalmology Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd., Dorval,

More information

8/7/12. Anterior Seg Grand Rounds Case III. New Advances in the Management of Viral Eye Disease. Slit lamp exam: Sign: 68 y.o.

8/7/12. Anterior Seg Grand Rounds Case III. New Advances in the Management of Viral Eye Disease. Slit lamp exam: Sign: 68 y.o. New Advances in the Management of Viral Eye Disease Anterior Seg Grand Rounds Case III 68 y.o. Caucasian female!! Dr.Paul Karpecki!! Corneal Services and Ocular Disease Research!! Koffler Vision Group

More information

Differential Diagnosis of Conjunctivitis and Keratoconjunctivitis

Differential Diagnosis of Conjunctivitis and Keratoconjunctivitis Differential Diagnosis of Conjunctivitis and Keratoconjunctivitis Dr. Victor Malinovsky 2006 Mechanical-Physical Trauma Corneal Abrasions Abrasions (interpalpebral/variable): a focal loss of epithelium

More information

PHARMACOLOGY Class: Ketorolac trometamol is a member of the pyrrolo-pyrolle group of non-steroidal antiinflammatory

PHARMACOLOGY Class: Ketorolac trometamol is a member of the pyrrolo-pyrolle group of non-steroidal antiinflammatory ACULAR Eye Drops NAME OF THE DRUG Non-proprietary name: ketorolac trometamol. Chemical Structure: Chemical Name: ( )-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol

More information

PGAs. Glaucoma Pharmacology A-Z. Selecting Therapy. PGAs Prostaglandin analogs. Prostaglandin Side Effects 1/6/2014

PGAs. Glaucoma Pharmacology A-Z. Selecting Therapy. PGAs Prostaglandin analogs. Prostaglandin Side Effects 1/6/2014 PGAs Glaucoma Pharmacology A-Z Eric E. Schmidt, O.D. Omni Eye Specialists Wilmington, NC schmidtyvision@msn.com QHS dosing Long duration of action Flatten diurnal curve Effective on trough and peak IOP

More information

Herpetic Eye Disease Jason Duncan, OD, FAAO Diplomate, American Board of Optometry Associate Professor, Southern College of Optometry

Herpetic Eye Disease Jason Duncan, OD, FAAO Diplomate, American Board of Optometry Associate Professor, Southern College of Optometry Herpetic Eye Disease Jason Duncan, OD, FAAO Diplomate, American Board of Optometry Associate Professor, Southern College of Optometry I have what?! How to break the news Meet the Herpes Quick virology

More information

Case History. The SEVEN HABITS of Highly Effective Anterior Uveitis Management. SLEx findings: SLEx corneal findings: y.o.

Case History. The SEVEN HABITS of Highly Effective Anterior Uveitis Management. SLEx findings: SLEx corneal findings: y.o. The SEVEN HABITS of Highly Effective Anterior Uveitis Management Case History! 68 y.o. Caucasian female of photophobia and blurred vision! As well as a headache over right eye for 2 days! Complains Paul

More information

Outline. Financial Disclosures. Outline. Importance. Importance 2/13/2014

Outline. Financial Disclosures. Outline. Importance. Importance 2/13/2014 Brad Genereux, OD February 8 th, 2014 Anti-infective (bacterial, viral, fungal) Financial Disclosures No disclosures Importance Know drugs you re administering to patient Patient education Reactions Triage

More information

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v. PRESCRIBING INFORMATION WITH CONSUMER INFORMATION Pr MYDRIACYL tropicamide ophthalmic solution, USP 0.5% and 1% w/v Anticholinergic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga, ON L5N 8C7 www.alcon.ca

More information

TOBAFLAM Eye Drops (Loteprednol etabonate 0.5% + Tobramycin 0.3%)

TOBAFLAM Eye Drops (Loteprednol etabonate 0.5% + Tobramycin 0.3%) Published on: 23 Sep 2014 TOBAFLAM Eye Drops (Loteprednol etabonate 0.5% + Tobramycin 0.3%) Composition Loteprednol Etabonate 5 mg (0.5% w/v) Tobramycin...3 mg (0.3% w/v) Benzalkonium Chloride.. 0.01%

More information

BNF CHAPTER 11: EYE 1 January 2018

BNF CHAPTER 11: EYE 1 January 2018 BNF CHAPTER 11: EYE 1 BNF 11.3.1 ANTIBACTERIALS First Choice. Broad spectrum. Chloramphenicol 0.5% Eye Drops Administration Alternative Administration Eye drops, apply 1 drop at least every 2 hours then

More information

Glaucoma Disease Progression Role of Intra Ocular Pressure. Is Good Enough, Low Enough?

Glaucoma Disease Progression Role of Intra Ocular Pressure. Is Good Enough, Low Enough? Glaucoma Disease Progression Role of Intra Ocular Pressure Is Good Enough, Low Enough? Glaucoma Diseases Progression Key Considerations Good number of patients may be diagnosed only after some damage the

More information

Dapiprazole Hydrochloride 0.5% Erythromycin. Antibacterial Medications. Comprehensive Pharmacology Update

Dapiprazole Hydrochloride 0.5% Erythromycin. Antibacterial Medications. Comprehensive Pharmacology Update Comprehensive Pharmacology Update Ron Melton, OD, FAAO Randall Thomas, OD, MPH, FAAO www.eyeupdate.com 2009: A TPA Odyssey Are We There Yet? Vision Institute of Canada Annual Fall Conference and Trade

More information

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye...

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye... Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye... This Allergan sponsored session was held on July 24, 2005, Hotel Satya Ashoka, Jabalpur. The session was followed

More information

Case no.4. Subjective. Subjective (2) Caucasian female, 62 Y.O., consulting for a XXX opinion on her condition.

Case no.4. Subjective. Subjective (2) Caucasian female, 62 Y.O., consulting for a XXX opinion on her condition. Case no.4 Contact lenses: cause Subjective Caucasian female, 62 Y.O., consulting for a XXX opinion on her condition. Works as a lab technician for a veterenary surgeon No exposure to chemicals Had been

More information

Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS:

Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS: 0BCore Safety Profile Active substance: Betaxolol eyedrops Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS: HU/H/PSUR/0010/002 Date of FAR: 20.03.2013 4.2 Posology

More information

Common Eye Problems. Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc.

Common Eye Problems. Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc. Common Eye Problems for Subspecialists 2018 Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc. I have no financial disclosures to make. Goals of Course Evaluation and management of the red

More information

OOGZIEKTEN VOOR DE HUISARTS F. GOES, JR.

OOGZIEKTEN VOOR DE HUISARTS F. GOES, JR. OOGZIEKTEN VOOR DE HUISARTS F. GOES, JR. HET RODE OOG F. GOES, JR. Condition Signs Symptoms Causes Conjunctivitis Viral Normal vision, normal pupil size Mild to no pain, diffuse Adenovirus (most common),

More information

PRED-G (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% sterile

PRED-G (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% sterile PRED-G (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% sterile PRED-G sterile ophthalmic ointment is a topical anti-inflammatory/anti-infective combination product for ophthalmic

More information

Get a grip on your glaucoma Booklet 1

Get a grip on your glaucoma Booklet 1 Information for Patients Glaucoma services Welcome! Get a grip on your glaucoma Booklet 1 Group-based Glaucoma information Course Session 1 What happens in session 1? Finding out what questions you have

More information

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique Injection Technique Quick-Reference Guide PRECISION PROGRAM Companion booklet for the Video Guide to Injection Technique Available at www.ozurdexprecisionprogram.com Provides step-by-step directions with

More information

Ocular Allergy. Phil Lieberman, MD

Ocular Allergy. Phil Lieberman, MD Ocular Allergy Phil Lieberman, MD Disclosure Consultant/Advisory Board: Genentech, Meda, Mylan, Teva Speaker: Genentech, Meda, Merck, Mylan, Teva Learning Objectives Upon completion of this session, participants

More information

The Emergent Eye in the Acute Setting

The Emergent Eye in the Acute Setting The Emergent Eye in the Acute Setting Todd P. Margolis MD, PhD Professor of Ophthalmology & Director of the F.I. Proctor Foundation UCSF Physical Exam-- Visual Acuity Essential Corrected visual acuity

More information

Ophthalmology in Primary Care. Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc.

Ophthalmology in Primary Care. Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc. Ophthalmology in Primary Care Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc. No financial disclosures Objectives Red eye Nonvision threatening Vision threatening Cataracts Red Flag Signs

More information

LOWPROST Eye Drops (Bimatoprost Ophthalmic Solution 0.01%)

LOWPROST Eye Drops (Bimatoprost Ophthalmic Solution 0.01%) Published on: 14 Apr 2017 LOWPROST Eye Drops (Bimatoprost Ophthalmic Solution 0.01%) For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only Composition Each ml contains: Bimatoprost...

More information

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Package Leaflet - Information for the User TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Read all of this leaflet carefully before you start using this medicine because it

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Guidelines for the medical treatment of chronic open angle glaucoma and ocular hypertension Summary: DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Diagnosis and management of ocular hypertension (OHT)

More information

Ophthalmological preparations

Ophthalmological preparations Ophthalmological preparations Administration of eye preparations Preparations for the eye should be sterile when issued. Use of single-application containers is preferable; multiple-application preparations

More information

OPHTHALMIC GENERIC FORMULATIONS BY ADREA R. BENKOFF, M.D.

OPHTHALMIC GENERIC FORMULATIONS BY ADREA R. BENKOFF, M.D. OPHTHALMIC GENERIC FORMULATIONS BY ADREA R. BENKOFF, M.D. WHAT YOU NEED TO KNOW ABOUT OPHTHALMIC GENERICS GENERIC REQUIREMENTS WHO MAKES GENERIC OPHTHALMIC PRODUCTS DO THEY WORK AS WELL AS THE BRAND PRODUCT

More information

IOP measurements: 8.00 am (trough drug levels) and am (peak drug levels)(2 hours post dose)

IOP measurements: 8.00 am (trough drug levels) and am (peak drug levels)(2 hours post dose) This overview of 2% eye drops was presented by Dr. Ravin N. Das, at Hotel Satya Ashoka, on 19-6-2004 in place of Dr. H. S. Ray due to unforseen circumstances. This dinner meeting was sponsored by Cipla

More information

Ocular Allergies: Scratching the Surface. -20%-50% of the population has allergies -83% of allergy sufferers experience ocular symptoms

Ocular Allergies: Scratching the Surface. -20%-50% of the population has allergies -83% of allergy sufferers experience ocular symptoms How Many People Are Affected? Ocular Allergies: Scratching the Surface Mile Brujic, OD -20%-50% of the population has allergies -83% of allergy sufferers experience ocular symptoms Disclosure: I have no

More information

Long Term Care Formulary RS 14. RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5

Long Term Care Formulary RS 14. RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5 RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5 PREAMBLE Significance: Glaucoma occurs in 1-2% of white people aged over 40 years, rising to 5% at 70 years and exponentially with advancing

More information

Cataract Surgery Co-Management

Cataract Surgery Co-Management Cataract Surgery Co-Management Phacoemulsification, Clear-Lens Extraction, and LensX INCLUSION CRITERIA: Significant visual complaints (decreased VA, increased glare, decreased Activities of Daily Living

More information

Sepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital

Sepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital Sepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital 14 mo old w R eye cross (parents) 9 mo old R eye crossing getting worse for past

More information

Volume 9; Number 6 May 2015 PRESCRIBING FOR CHRONIC OPEN ANGLE GLAUCOMA (COAG) AND OCULAR HYPERTENSION (OHT)

Volume 9; Number 6 May 2015 PRESCRIBING FOR CHRONIC OPEN ANGLE GLAUCOMA (COAG) AND OCULAR HYPERTENSION (OHT) Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire

More information

Ophthalmology Times Case Study Yasmin Mali, MD. Case Study

Ophthalmology Times Case Study Yasmin Mali, MD. Case Study Ophthalmology Times Case Study Yasmin Mali, MD Case Study A 57 year old female with presented with ocular irritation and discomfort in both eyes for several months. Patient was previously started on a

More information

KEY MESSAGES. Details of the evidence supporting these recommendations can be found in the above CPG, available on the following websites:

KEY MESSAGES. Details of the evidence supporting these recommendations can be found in the above CPG, available on the following websites: QUICK REFERENCE FOR HEALTHCARE PROVIDERS KEY MESSAGES 1. Glaucoma is a chronic eye disease that damages the optic nerve, & can result in serious vision loss and irreversible blindness. 2. Glaucoma diagnosis

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 28 May 2008 COSOPT 20 mg/5 mg/ml, eye drops, solution in single dose container Box of 60 0.2 ml single dose containers

More information

[TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN. TRAVOPR-v

[TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN. TRAVOPR-v [TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN TRAVOPR-v2-270214 VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Studies estimated that 3-6 million people

More information

Conjunctivitis - Allergic, Seasonal & Perennial (1 of 6) Patient presents w/ symptoms suggestive of allergic conjunctivitis

Conjunctivitis - Allergic, Seasonal & Perennial (1 of 6) Patient presents w/ symptoms suggestive of allergic conjunctivitis , Seasonal & Perennial ( of 6) A B Patient presents w/ symptoms suggestive of allergic conjunctivitis Non-pharmacological therapy 2 DIAGNOSIS Does the clinical presentation confirm seasonal or perennial

More information

Innovation In Ophthalmics

Innovation In Ophthalmics Innovation In Ophthalmics Ophthalmic Innovation Summit @ AAO 2018 October 25, 2018 Mark Iwicki Chairman & CEO, Kala Pharmaceuticals Disclaimers and Notices This presentation contains forward-looking statements

More information

Chemical Names: Prednisolone acetate: 11ß,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate.

Chemical Names: Prednisolone acetate: 11ß,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate. PRED-G (gentamicin and prednisolone acetate ophthalmic suspension, USP) 0.3%/1% sterile DESCRIPTION PRED-G sterile ophthalmic suspension is a topical anti-inflammatory/anti-infective combination product

More information

Medical Treatment in Pediatric Glaucoma

Medical Treatment in Pediatric Glaucoma Medical Treatment in Pediatric Glaucoma By Nader Bayoumi, MD Lecturer of Ophthalmology Ophthalmology Department Alexandria University Alexandria, Egypt ESG 2012 Pediatric glaucoma is a surgical disease

More information

Drug Classifications

Drug Classifications CLASSIFICATIONS: QUIZ 2 Drug Classifications 1. Which category of drugs is used to relieve minor to severe pain? a. Alkylates b. Analgesics c. Angiotensin-converting enzyme inhibitors d. Androgens e. Anesthetics

More information

Speakers. Learning Objectives. Major Contributor. HPI Approach to the Patient with Red Eye. 1. Unilateral or bilateral?

Speakers. Learning Objectives. Major Contributor. HPI Approach to the Patient with Red Eye. 1. Unilateral or bilateral? Speakers John West, M.D. Katie West, 4 th year Optometry Student John West, M.S., M.D. McCook Clinic, P.C. McCook, Nebraska University of Nebraska Medical Center (Omaha, NE) Volunteer Faculty-Family Medicine

More information

The State of Therapeutics in Eye Care (Part II)

The State of Therapeutics in Eye Care (Part II) The State of Therapeutics in Eye Care (Part II) Ron Melton, OD, FAAO Randall Thomas, OD, MPH, FAAO The comprehensive ophthalmologist should be comfortable in using and prescribing the treatments for stages

More information

Elements for a public summary. VI.2.1 Overview of disease epidemiology

Elements for a public summary. VI.2.1 Overview of disease epidemiology VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology The term ocular hypertension usually refers to any situation in which the pressure inside the eye, called intraocular pressure,

More information

Neomycin B (R 1 =H, R 2 =CH 2 NH 2 ) Neomycin C (R 1 =CH 2 NH 2, R 2 =H) The chemical structure for the active ingredient Polymyxin B Sulfate is:

Neomycin B (R 1 =H, R 2 =CH 2 NH 2 ) Neomycin C (R 1 =CH 2 NH 2, R 2 =H) The chemical structure for the active ingredient Polymyxin B Sulfate is: MAXITROL * (neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment) Sterile DESCRIPTION MAXITROL (neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment) is a multiple

More information

Page 1 RED EYES. conjunctivitis keratitis episcleritis / scleritis. Frank Larkin Moorfields Eye Hospital. acute glaucoma anterior uveitis

Page 1 RED EYES. conjunctivitis keratitis episcleritis / scleritis. Frank Larkin Moorfields Eye Hospital. acute glaucoma anterior uveitis The RED EYE and ALLERGIC EYE DISEASE DIAGNOSIS & MANAGEMENT Frank Larkin Moorfields Eye Hospital RED EYES conjunctivitis keratitis episcleritis / scleritis acute glaucoma anterior uveitis post-op. / trauma

More information

INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998

INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVELTYS safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol

More information

DISCLOSURES. PEDIATRIC RED EYES Rachel M. Smith, OD, FCOVD HISTORY, HISTORY, HISTORY WHY RED EYES? EXAMINE THE EYE RED FLAGS TO REFER 3/25/2019

DISCLOSURES. PEDIATRIC RED EYES Rachel M. Smith, OD, FCOVD HISTORY, HISTORY, HISTORY WHY RED EYES? EXAMINE THE EYE RED FLAGS TO REFER 3/25/2019 DISCLOSURES Consultant/Speakers bureaus Research funding PEDIATRIC RED EYES Rachel M. Smith, OD, FCOVD Pediatric Optometrist Children s Hospital & Medical Center Stock ownership/corporate boards employment

More information

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0. PRESCRIBING INFORMATION Pr MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.1% w/w Pr MAXITROL* Neomycin and Polymyxin B

More information

Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology

Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Document type and title: Joint formulary - Ophthalmology Authorised document folder: New or replacing

More information

Strategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH

Strategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH Strategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH 43402 brujic@prodigy.net 419-261-9161 Summary As optometry s scope of practice continues

More information

AUSTRALIAN PRODUCT INFORMATION ACULAR (ketorolac trometamol) Eye Drops

AUSTRALIAN PRODUCT INFORMATION ACULAR (ketorolac trometamol) Eye Drops AUSTRALIAN PRODUCT INFORMATION ACULAR (ketorolac trometamol) Eye Drops 1 NAME OF THE MEDICINE Ketorolac trometamol 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACULAR contains ketorolac trometamol 5 mg/ml.

More information